Biomerica, Inc. (BMRA)
USD 0.54
(-5.4%)
USD 0.54
(-5.4%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -6.36 Million USD | 11.85% |
| 2023 | -7.22 Million USD | -59.31% |
| 2022 | -4.53 Million USD | 30.49% |
| 2021 | -6.52 Million USD | -171.45% |
| 2020 | -2.4 Million USD | 0.41% |
| 2019 | -2.41 Million USD | -62.83% |
| 2018 | -1.48 Million USD | -55.22% |
| 2017 | -954.63 Thousand USD | -15.44% |
| 2016 | -826.95 Thousand USD | -23.32% |
| 2015 | -670.59 Thousand USD | -50.16% |
| 2014 | -446.59 Thousand USD | -186.88% |
| 2013 | 514 Thousand USD | 1.78% |
| 2012 | 504.99 Thousand USD | 481.82% |
| 2011 | -132.26 Thousand USD | 63.72% |
| 2010 | -364.52 Thousand USD | -247.19% |
| 2009 | 247.65 Thousand USD | -51.39% |
| 2008 | 509.48 Thousand USD | -2.17% |
| 2007 | 520.79 Thousand USD | 636.4% |
| 2006 | -97.09 Thousand USD | 58.64% |
| 2005 | -234.76 Thousand USD | 25.74% |
| 2004 | -316.13 Thousand USD | -50.63% |
| 2003 | -209.88 Thousand USD | 54.9% |
| 2002 | -465.42 Thousand USD | 31.91% |
| 2001 | -683.58 Thousand USD | 83.69% |
| 2000 | -4.19 Million USD | -1296.67% |
| 1999 | -300 Thousand USD | -250.0% |
| 1998 | 200 Thousand USD | -66.67% |
| 1997 | 600 Thousand USD | -14.29% |
| 1996 | 700 Thousand USD | 75.0% |
| 1995 | 400 Thousand USD | 100.0% |
| 1994 | 200 Thousand USD | 166.67% |
| 1993 | -300 Thousand USD | 78.57% |
| 1992 | -1.4 Million USD | 26.32% |
| 1991 | -1.9 Million USD | -733.33% |
| 1990 | 300 Thousand USD | 133.33% |
| 1989 | -900 Thousand USD | 43.75% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.6 Million USD | -30.52% |
| 2024 Q1 | -1.23 Million USD | 32.89% |
| 2024 Q4 | -1.52 Million USD | 23.6% |
| 2024 Q3 | -2 Million USD | -24.38% |
| 2024 FY | -6.36 Million USD | 11.85% |
| 2023 FY | -7.22 Million USD | -59.31% |
| 2023 Q3 | -1.65 Million USD | 0.9% |
| 2023 Q1 | -2.06 Million USD | -17.86% |
| 2023 Q2 | -1.66 Million USD | 19.51% |
| 2023 Q4 | -1.83 Million USD | -11.18% |
| 2022 Q4 | -1.75 Million USD | -1533.82% |
| 2022 Q1 | -1.54 Million USD | -2.27% |
| 2022 Q2 | -1.12 Million USD | 26.66% |
| 2022 Q3 | -107.49 Thousand USD | 90.48% |
| 2022 FY | -4.53 Million USD | 30.49% |
| 2021 FY | -6.52 Million USD | -171.45% |
| 2021 Q1 | -1.65 Million USD | -239.52% |
| 2021 Q3 | -1.88 Million USD | -27.06% |
| 2021 Q2 | -1.47 Million USD | 10.66% |
| 2021 Q4 | -1.5 Million USD | 19.89% |
| 2020 Q1 | -509.55 Thousand USD | 33.38% |
| 2020 Q3 | -914.88 Thousand USD | -86.81% |
| 2020 Q2 | -489.74 Thousand USD | 3.89% |
| 2020 FY | -2.4 Million USD | 0.41% |
| 2020 Q4 | -487.86 Thousand USD | 46.68% |
| 2019 Q1 | -454.78 Thousand USD | 29.4% |
| 2019 Q2 | -485.93 Thousand USD | -6.85% |
| 2019 Q3 | -707.24 Thousand USD | -45.54% |
| 2019 Q4 | -764.81 Thousand USD | -8.14% |
| 2019 FY | -2.41 Million USD | -62.83% |
| 2018 Q2 | -288.73 Thousand USD | -27.74% |
| 2018 Q1 | -226.02 Thousand USD | 35.69% |
| 2018 Q3 | -322.84 Thousand USD | -11.81% |
| 2018 FY | -1.48 Million USD | -55.22% |
| 2018 Q4 | -644.14 Thousand USD | -99.52% |
| 2017 Q4 | -351.44 Thousand USD | -10.61% |
| 2017 Q1 | -65.63 Thousand USD | 75.86% |
| 2017 FY | -954.63 Thousand USD | -15.44% |
| 2017 Q2 | -219.53 Thousand USD | -234.5% |
| 2017 Q3 | -317.72 Thousand USD | -44.72% |
| 2016 Q2 | -209.77 Thousand USD | -175.17% |
| 2016 Q4 | -271.83 Thousand USD | -1.01% |
| 2016 Q1 | -76.23 Thousand USD | -24.79% |
| 2016 FY | -826.95 Thousand USD | -23.32% |
| 2016 Q3 | -269.1 Thousand USD | -28.28% |
| 2015 FY | -670.59 Thousand USD | -50.16% |
| 2015 Q3 | -135.53 Thousand USD | 45.76% |
| 2015 Q4 | -61.08 Thousand USD | 54.93% |
| 2015 Q1 | -224.11 Thousand USD | -286.42% |
| 2015 Q2 | -249.86 Thousand USD | -11.49% |
| 2014 Q1 | -173.76 Thousand USD | -1081.96% |
| 2014 FY | -446.59 Thousand USD | -186.88% |
| 2014 Q3 | 32.61 Thousand USD | 113.18% |
| 2014 Q2 | -247.5 Thousand USD | -42.43% |
| 2014 Q4 | -57.99 Thousand USD | -277.81% |
| 2013 FY | 514 Thousand USD | 1.78% |
| 2013 Q4 | 17.69 Thousand USD | 127.94% |
| 2013 Q3 | -63.33 Thousand USD | -125.59% |
| 2013 Q2 | 247.5 Thousand USD | -20.71% |
| 2013 Q1 | 312.15 Thousand USD | 424.46% |
| 2012 Q2 | 194.08 Thousand USD | 66.03% |
| 2012 Q3 | 134.49 Thousand USD | -30.7% |
| 2012 Q4 | 59.51 Thousand USD | -55.75% |
| 2012 Q1 | 116.9 Thousand USD | 857.57% |
| 2012 FY | 504.99 Thousand USD | 481.82% |
| 2011 FY | -132.26 Thousand USD | 63.72% |
| 2011 Q3 | 73.01 Thousand USD | 141.11% |
| 2011 Q1 | -12.23 Thousand USD | 93.1% |
| 2011 Q2 | -177.61 Thousand USD | -1352.29% |
| 2011 Q4 | -15.43 Thousand USD | -121.13% |
| 2010 Q4 | -177.21 Thousand USD | -255.21% |
| 2010 Q2 | -306.19 Thousand USD | -6588.64% |
| 2010 FY | -364.52 Thousand USD | -247.19% |
| 2010 Q1 | 4719.00 USD | 173.39% |
| 2010 Q3 | 114.17 Thousand USD | 137.29% |
| 2009 Q3 | 214.1 Thousand USD | 299.59% |
| 2009 Q4 | -6430.00 USD | -103.0% |
| 2009 Q1 | 147.25 Thousand USD | -13.03% |
| 2009 Q2 | -107.27 Thousand USD | -172.84% |
| 2009 FY | 247.65 Thousand USD | -51.39% |
| 2008 Q4 | 169.32 Thousand USD | 43.48% |
| 2008 FY | 509.48 Thousand USD | -2.17% |
| 2008 Q2 | 6263.00 USD | -97.08% |
| 2008 Q1 | 214.41 Thousand USD | -19.29% |
| 2008 Q3 | 118 Thousand USD | 1784.22% |
| 2007 Q3 | 95.75 Thousand USD | -16.85% |
| 2007 Q1 | 44.19 Thousand USD | -33.24% |
| 2007 FY | 520.79 Thousand USD | 636.4% |
| 2007 Q4 | 265.67 Thousand USD | 177.45% |
| 2007 Q2 | 115.16 Thousand USD | 160.58% |
| 2006 Q3 | 36.93 Thousand USD | 135.35% |
| 2006 Q2 | -104.48 Thousand USD | -9.15% |
| 2006 Q1 | -95.72 Thousand USD | -46.87% |
| 2006 FY | -97.09 Thousand USD | 58.64% |
| 2006 Q4 | 66.19 Thousand USD | 79.23% |
| 2005 Q3 | 59.88 Thousand USD | 147.43% |
| 2005 FY | -234.76 Thousand USD | 25.74% |
| 2005 Q2 | -126.26 Thousand USD | -22.39% |
| 2005 Q1 | -103.17 Thousand USD | -493.08% |
| 2005 Q4 | -65.18 Thousand USD | -208.83% |
| 2004 Q3 | 97.85 Thousand USD | 175.77% |
| 2004 Q1 | -311.09 Thousand USD | -460.9% |
| 2004 FY | -316.13 Thousand USD | -50.63% |
| 2004 Q4 | 26.24 Thousand USD | -73.18% |
| 2004 Q2 | -129.14 Thousand USD | 58.49% |
| 2003 Q1 | -150.55 Thousand USD | -328.04% |
| 2003 FY | -209.88 Thousand USD | 54.9% |
| 2003 Q4 | 86.19 Thousand USD | 5200.53% |
| 2003 Q3 | -1690.00 USD | 98.84% |
| 2003 Q2 | -145.43 Thousand USD | 3.4% |
| 2002 Q3 | 30.57 Thousand USD | 136.84% |
| 2002 Q2 | -82.98 Thousand USD | 78.36% |
| 2002 Q1 | -383.53 Thousand USD | -125.51% |
| 2002 FY | -465.42 Thousand USD | 31.91% |
| 2002 Q4 | -35.17 Thousand USD | -215.05% |
| 2001 FY | -683.58 Thousand USD | 83.69% |
| 2001 Q1 | -1 Million USD | 16.25% |
| 2001 Q2 | -637.31 Thousand USD | 36.46% |
| 2001 Q3 | -545.61 Thousand USD | 14.39% |
| 2001 Q4 | 1.5 Million USD | 375.51% |
| 2000 Q4 | -1.19 Million USD | -18.16% |
| 2000 Q2 | -800 Thousand USD | -14.29% |
| 2000 Q1 | -700 Thousand USD | -800.0% |
| 2000 Q3 | -1.01 Million USD | -26.7% |
| 2000 FY | -4.19 Million USD | -1296.67% |
| 1999 FY | -300 Thousand USD | -250.0% |
| 1999 Q1 | -100 Thousand USD | -200.0% |
| 1999 Q2 | -100 Thousand USD | 0.0% |
| 1999 Q3 | -200 Thousand USD | -100.0% |
| 1999 Q4 | 100 Thousand USD | 150.0% |
| 1998 Q1 | 100 Thousand USD | -50.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1998 FY | 200 Thousand USD | -66.67% |
| 1997 Q4 | 200 Thousand USD | 100.0% |
| 1997 FY | 600 Thousand USD | -14.29% |
| 1997 Q1 | 200 Thousand USD | -50.0% |
| 1997 Q2 | 100 Thousand USD | -50.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1996 FY | 700 Thousand USD | 75.0% |
| 1996 Q4 | 400 Thousand USD | 300.0% |
| 1996 Q1 | 100 Thousand USD | -50.0% |
| 1996 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 FY | 400 Thousand USD | 100.0% |
| 1995 Q4 | 200 Thousand USD | 100.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q1 | - USD | -100.0% |
| 1994 Q4 | 200 Thousand USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q1 | - USD | 100.0% |
| 1994 FY | 200 Thousand USD | 166.67% |
| 1993 Q1 | 100 Thousand USD | 111.11% |
| 1993 FY | -300 Thousand USD | 78.57% |
| 1993 Q4 | -200 Thousand USD | -100.0% |
| 1993 Q3 | -100 Thousand USD | 0.0% |
| 1993 Q2 | -100 Thousand USD | -200.0% |
| 1992 Q3 | -500 Thousand USD | -150.0% |
| 1992 Q4 | -900 Thousand USD | -80.0% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q2 | -200 Thousand USD | 0.0% |
| 1992 FY | -1.4 Million USD | 26.32% |
| 1991 FY | -1.9 Million USD | -733.33% |
| 1991 Q1 | - USD | -100.0% |
| 1991 Q2 | -600 Thousand USD | 0.0% |
| 1991 Q3 | -400 Thousand USD | 33.33% |
| 1991 Q4 | -800 Thousand USD | -100.0% |
| 1990 Q1 | -100 Thousand USD | 0.0% |
| 1990 Q3 | -100 Thousand USD | -133.33% |
| 1990 Q2 | 300 Thousand USD | 400.0% |
| 1990 Q4 | 300 Thousand USD | 400.0% |
| 1990 FY | 300 Thousand USD | 133.33% |
| 1989 Q3 | -200 Thousand USD | -166.67% |
| 1989 Q4 | -100 Thousand USD | 50.0% |
| 1989 FY | -900 Thousand USD | 43.75% |
| 1989 Q1 | 300 Thousand USD | 110.0% |
| 1989 Q2 | 300 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 55.665% |
| Cerus Corporation | -30.05 Million USD | 78.814% |
| OrthoPediatrics Corp. | -25.76 Million USD | 75.289% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 40.055% |
| Talis Biomedical Corporation | -66.81 Million USD | 90.471% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 63.188% |
| Inogen, Inc. | -109.38 Million USD | 94.179% |
| Spectral AI, Inc. | -12.98 Million USD | 50.963% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 89.827% |
| CVRx, Inc. | -43.1 Million USD | 85.228% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -80.471% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 48.769% |
| Orthofix Medical Inc. | -139.11 Million USD | 95.423% |
| Venus Concept Inc. | -28.3 Million USD | 77.509% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 88.215% |
| Bioventus Inc. | -81.72 Million USD | 92.209% |
| BrainsWay Ltd. | -4.92 Million USD | -29.227% |
| Envoy Medical, Inc. | -18.37 Million USD | 65.342% |
| electroCore, Inc. | -18.8 Million USD | 66.142% |
| IceCure Medical Ltd | -15.57 Million USD | 59.123% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 86.867% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 63.128% |
| MaxCyte, Inc. | -48.29 Million USD | 86.818% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 46.743% |
| Nexalin Technology, Inc. | -5.69 Million USD | -11.774% |
| PAVmed Inc | -68.79 Million USD | 90.745% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 88.744% |
| RxSight, Inc. | -50.08 Million USD | 87.288% |
| Sight Sciences, Inc. | -57.27 Million USD | 88.883% |
| SI-BONE, Inc. | -46.93 Million USD | 86.433% |
| TELA Bio, Inc. | -44.07 Million USD | 85.554% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 88.242% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 87.62% |
| LivaNova PLC | -68.49 Million USD | 90.705% |
| 908 Devices Inc. | -42.75 Million USD | 85.109% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 96.328% |
| Nemaura Medical Inc. | -9.59 Million USD | 33.644% |
| NeuroPace, Inc. | -27.17 Million USD | 76.57% |
| LENSAR, Inc. | -12.22 Million USD | 47.935% |
| Apyx Medical Corporation | -17.25 Million USD | 63.109% |
| Cutera, Inc. | -156.23 Million USD | 95.925% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 26.0% |
| BioSig Technologies, Inc. | -28.51 Million USD | 77.669% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 92.735% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 71.634% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 105.709% |
| Axonics, Inc. | -26.05 Million USD | 75.565% |
| Outset Medical, Inc. | -169.77 Million USD | 96.25% |
| IRIDEX Corporation | -10 Million USD | 36.375% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 94.168% |
| IRadimed Corporation | 20.03 Million USD | 131.779% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 22.777% |
| INVO Bioscience, Inc. | -6.76 Million USD | 5.913% |
| Telesis Bio, Inc. | -35.15 Million USD | 81.886% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 144.431% |
| Varex Imaging Corporation | 32.1 Million USD | 119.835% |
| Quipt Home Medical Corp. | 3.91 Million USD | 262.465% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 47.523% |
| Pulmonx Corporation | -61.93 Million USD | 89.72% |
| Dynatronics Corporation | -2.27 Million USD | -180.108% |
| Modular Medical, Inc. | -17.52 Million USD | 63.677% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 56.507% |
| Semler Scientific, Inc. | 22.25 Million USD | 128.608% |
| InMode Ltd. | 195.66 Million USD | 103.254% |
| Bruker Corporation | 436.9 Million USD | 101.457% |
| Cytosorbents Corporation | -31.2 Million USD | 79.599% |
| DexCom, Inc. | 597.7 Million USD | 101.065% |
| Align Technology, Inc. | 643.33 Million USD | 100.99% |
| Viveve Medical, Inc. | -21.55 Million USD | 70.459% |
| ZimVie Inc. | -30.93 Million USD | 79.421% |
| Movano Inc. | -29.69 Million USD | 78.555% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 77.134% |
| Nexalin Technology, Inc. | -5.69 Million USD | -11.774% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -80.471% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 97.27% |
| Profound Medical Corp. | -28.61 Million USD | 77.75% |
| Insulet Corporation | 220 Million USD | 102.894% |
| enVVeno Medical Corporation | -25.23 Million USD | 74.772% |
| Surmodics, Inc. | -5.64 Million USD | -12.79% |
| iCAD, Inc. | -7.68 Million USD | 17.193% |
| Nuwellis, Inc. | -17.63 Million USD | 63.885% |
| Biotricity, Inc. | -8.82 Million USD | 27.879% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 94.913% |
| Aethlon Medical, Inc. | -12.63 Million USD | 49.614% |
| InspireMD, Inc. | -21.14 Million USD | 69.886% |
| PAVmed Inc. | -68.79 Million USD | 90.745% |
| BIOLASE, Inc. | -17.93 Million USD | 64.504% |
| Beyond Air, Inc. | -63 Million USD | 89.895% |
| FONAR Corporation | 16.53 Million USD | 138.505% |
| AxoGen, Inc. | -21.46 Million USD | 70.334% |
| Vivani Medical, Inc. | -26.96 Million USD | 76.388% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 135.292% |
| Inari Medical, Inc. | -14.03 Million USD | 54.625% |
| UFP Technologies, Inc. | 57.66 Million USD | 111.042% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -29.211% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -0.971% |
| Tenon Medical, Inc. | -15.72 Million USD | 59.515% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 14.811% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 85.091% |
| AdaptHealth Corp. | -598.4 Million USD | 98.936% |
| Sintx Technologies, Inc. | -13.35 Million USD | 52.336% |
| NanoVibronix, Inc. | -3.43 Million USD | -85.303% |
| Quanterix Corporation | -49.7 Million USD | 87.189% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 47.523% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -1566.754% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 98.096% |
| TransMedics Group, Inc. | -28.72 Million USD | 77.836% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 73.035% |
| NeuroMetrix, Inc. | -7.15 Million USD | 10.97% |
| Hyperfine, Inc. | -48.11 Million USD | 86.767% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 90.209% |
| Bone Biologics Corporation | -9.42 Million USD | 32.469% |
| AVITA Medical, Inc. | -40.4 Million USD | 84.241% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 38.252% |
| Silk Road Medical, Inc | -59.27 Million USD | 89.258% |